Adherium Limited (ASX:ADR) a provider of integrated digital health solutions, reported earnings of AUD$1,145,000 ($876,000) for the quarter ended 31 March 2023, compared to AUD$294,000 in the preceding quarter.

This increase is largely attributed to sales to a new US customer for data fees and digital sensors, and AUD$792,000 in contract program fees for the UK National Health Service Small Business Research Initiative.

The company also secured US FDA 510(k) clearance for its new next-generation Hailie sensor with physiological parameters, and received Australian TGA approval for the same product.